Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 3289 | 1386 | 32.1 | 71% |
Classes in level above (level 3) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 183 | 51952 | HEPATOCELLULAR CARCINOMA//CONTRAST MEDIA//LIVER RESECTION |
Classes in level below (level 1) |
| ID, lev. below | Publications | Label for level below |
|---|---|---|
| 14412 | 705 | PHARMACEUT MED BIOTECHNOL//EQUIPE PHARM BIOGALEN//EQUIPE GENIE PHARMACOTECH |
| 22596 | 320 | LYMPHATIC SYSTEM MR//LYMPHOGRAPHY//INTERSTITIAL MR LYMPHOGRAPHY |
| 24800 | 251 | ACTIVATED CARBON PARTICLES//LYMPH NODE TARGETING//LYMPHATIC TARGETING |
| 34949 | 58 | MCA RH7777//LIVER ANGIOGRAPHY//INTERVENT RADIOL RADIOL |
| 35131 | 52 | TIP30//EASTERN HOSP HEPATOBILIARY SURG//CC3 |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TIP30 | Author keyword | 30 | 84% | 1% | 16 |
| 2 | LYMPHATIC SYSTEM MR | Author keyword | 15 | 67% | 1% | 14 |
| 3 | LYMPHOGRAPHY | Author keyword | 9 | 23% | 2% | 32 |
| 4 | INTERSTITIAL MR LYMPHOGRAPHY | Author keyword | 6 | 80% | 0% | 4 |
| 5 | PHARMACEUT MED BIOTECHNOL | Address | 6 | 80% | 0% | 4 |
| 6 | IODINATED NANOPARTICLES | Author keyword | 6 | 100% | 0% | 4 |
| 7 | EQUIPE PHARM BIOGALEN | Address | 5 | 44% | 1% | 8 |
| 8 | ACTIVATED CARBON PARTICLES | Author keyword | 4 | 50% | 0% | 6 |
| 9 | EQUIPE GENIE PHARMACOTECH | Address | 4 | 75% | 0% | 3 |
| 10 | IN VIVO SCANNING | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | TIP30 | 30 | 84% | 1% | 16 | Search TIP30 | Search TIP30 |
| 2 | LYMPHATIC SYSTEM MR | 15 | 67% | 1% | 14 | Search LYMPHATIC+SYSTEM++MR | Search LYMPHATIC+SYSTEM++MR |
| 3 | LYMPHOGRAPHY | 9 | 23% | 2% | 32 | Search LYMPHOGRAPHY | Search LYMPHOGRAPHY |
| 4 | INTERSTITIAL MR LYMPHOGRAPHY | 6 | 80% | 0% | 4 | Search INTERSTITIAL+MR+LYMPHOGRAPHY | Search INTERSTITIAL+MR+LYMPHOGRAPHY |
| 5 | IODINATED NANOPARTICLES | 6 | 100% | 0% | 4 | Search IODINATED+NANOPARTICLES | Search IODINATED+NANOPARTICLES |
| 6 | ACTIVATED CARBON PARTICLES | 4 | 50% | 0% | 6 | Search ACTIVATED+CARBON+PARTICLES | Search ACTIVATED+CARBON+PARTICLES |
| 7 | IN VIVO SCANNING | 4 | 75% | 0% | 3 | Search IN+VIVO+SCANNING | Search IN+VIVO+SCANNING |
| 8 | LYMPH NODE TARGETING | 4 | 75% | 0% | 3 | Search LYMPH+NODE+TARGETING | Search LYMPH+NODE+TARGETING |
| 9 | MR LYMPHOGRAPHY | 4 | 41% | 1% | 7 | Search MR+LYMPHOGRAPHY | Search MR+LYMPHOGRAPHY |
| 10 | CT CONTRAST AGENT | 3 | 57% | 0% | 4 | Search CT+CONTRAST+AGENT | Search CT+CONTRAST+AGENT |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | IOPROMIDE CARRYING LIPOSOMES | 27 | 83% | 1% | 15 |
| 2 | EOE 13 | 21 | 90% | 1% | 9 |
| 3 | IODINATED LIPID EMULSION | 21 | 85% | 1% | 11 |
| 4 | MR LYMPHOGRAPHY | 20 | 49% | 2% | 29 |
| 5 | POLYIODINATED TRIGLYCERIDE ANALOGS | 18 | 89% | 1% | 8 |
| 6 | BLOOD POOL | 18 | 33% | 3% | 44 |
| 7 | BISMUTH SULFIDE NANOPARTICLES | 16 | 58% | 1% | 18 |
| 8 | INTRAVENOUS CONTRAST AGENT | 14 | 100% | 1% | 7 |
| 9 | SMALL ANIMAL CT | 13 | 80% | 1% | 8 |
| 10 | TIP30 | 11 | 78% | 1% | 7 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Nano-Sized CT Contrast Agents | 2013 | 54 | 195 | 30% |
| Nanoparticulate X-ray Computed Tomography Contrast Agents: From Design Validation to in Vivo Applications | 2012 | 55 | 41 | 39% |
| Nanoparticles as computed tomography contrast agents: current status and future perspectives | 2012 | 47 | 66 | 42% |
| In vivo small-animal imaging using micro-CT and digital subtraction angiography | 2008 | 86 | 107 | 44% |
| X-ray-Computed Tomography Contrast Agents | 2013 | 33 | 234 | 32% |
| Lymphatic targeting with nanoparticulate system | 2001 | 105 | 29 | 62% |
| Application of micro-CT in small animal imaging | 2010 | 70 | 100 | 38% |
| Liposomes to target the lymphatics by subcutaneous administration | 2001 | 147 | 55 | 42% |
| Gold nanoparticles as contrast agents in x-ray imaging and computed tomography | 2015 | 1 | 126 | 31% |
| Nanoparticle contrast agents for computed tomography: a focus on micelles | 2014 | 7 | 151 | 40% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PHARMACEUT MED BIOTECHNOL | 6 | 80% | 0.3% | 4 |
| 2 | EQUIPE PHARM BIOGALEN | 5 | 44% | 0.6% | 8 |
| 3 | EQUIPE GENIE PHARMACOTECH | 4 | 75% | 0.2% | 3 |
| 4 | CQM | 3 | 19% | 1.2% | 16 |
| 5 | CQM QUIM MADEIRA | 3 | 29% | 0.6% | 8 |
| 6 | VIVO MICROSCOPY | 2 | 14% | 1.2% | 16 |
| 7 | EDWARD B SINGLETON PEDIAT RADIOL | 2 | 28% | 0.5% | 7 |
| 8 | EASTERN HOSP HEPATOBILIARY SURG | 2 | 36% | 0.4% | 5 |
| 9 | RADIOTECH SCI | 2 | 36% | 0.3% | 4 |
| 10 | E UNIV | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 2) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000022658 | FOCAL NODULAR HYPERPLASIA//GD EOB DTPA//GADOXETIC ACID |
| 2 | 0.0000018418 | MAGNETIC NANOPARTICLES//MAGNETIC DRUG TARGETING//MAGNETIC HYPERTHERMIA |
| 3 | 0.0000016863 | OPT IMAGING//PHOTOTHERMAL THERAPY//PHOTOACOUSTIC IMAGING |
| 4 | 0.0000016472 | MANGANISM//MANGANESE//RELAXIVITY |
| 5 | 0.0000015342 | CONTRAST INDUCED NEPHROPATHY//NEPHROGENIC SYSTEMIC FIBROSIS//CONTRAST MEDIA |
| 6 | 0.0000014582 | DCE MRI//CT PERFUSION//INTRAVOXEL INCOHERENT MOTION |
| 7 | 0.0000012444 | BLOOD SUBSTITUTES//BLOOD SUBSTITUTE//PARTIAL LIQUID VENTILATION |
| 8 | 0.0000010205 | HYPERPOLARIZED HE 3//HYPERPOLARIZED GAS//LUNG MRI |
| 9 | 0.0000010017 | NANOTOXICOLOGY//PROTEIN CORONA//NANOTOXICITY |
| 10 | 0.0000009691 | SOLID LIPID NANOPARTICLES//NANOSTRUCTURED LIPID CARRIERS//NANOSUSPENSION |